February 6, 2008 Solutia Inc
Solutia Files Suit
Against Citi, Goldman Sachs and Deutsche Bank
Complaint Seeks Enforcement of Commitment to Provide Solutia's
Exit Financing
Solutia Inc. today filed a complaint in the U.S. Bankruptcy Court
for the Southern District of New York against the three banks
that had executed a firm commitment to fund a $2
billion exit financing package for Solutia, but to date have
refused to meet this commitment. These banks are Citigroup Global
Markets Inc., Goldman Sachs Credit Partners L.P., and Deutsche
Bank Securities Inc. Solutia is seeking a court order requiring
the banks to meet their commitment and fund Solutia's exit from
bankruptcy. The complaint also asserts that the banks should be
stopped from invoking the clause they claim relieves them of
their obligation due to their improper conduct and
misrepresentations to the company, and further claims that the
banks fraudulently induced Solutia to enter into the initial
engagement by promising that the financing was firmly committed.
Solutia and the banks have agreed that Solutia's claim to require
immediate funding of the $2 billion package should be heard by
the Court on an expedited basis, with the trial to conclude by
the end of February - prior to the expiration of the banks'
commitment.
gThis
is not a ebest efforts' agreement,h said Jeffry N. Quinn, chairman,
president and CEO of Solutia Inc. gSolutia agreed to pay the banks an
enhanced fee in exchange for their firm commitment to fund the
full $2 billion exit financing facility -- regardless of the
results of the syndication process. We are extremely disappointed
by their refusal to meet this commitment and have no choice but
to pursue all of our legal remedies.h
On October 25, 2007 , the banks executed a firm commitment to
fund a $2 billion exit financing package for Solutia. These
substantial, custom credit facilities and arrangements were
specifically tailored to facilitate Solutia's prompt emergence
from Chapter 11. On November 20, 2007 , the bankruptcy court
approved the exit financing package. Nine days later, in reliance on the
banks' firm lending commitment, the court found the plan of
reorganization to be feasible and confirmed the plan. However, in late January - shortly
before the anticipated closing of the exit facility and Solutia's
long-awaited emergence from Chapter 11 - the banks notified
Solutia that they were refusing to provide the funding, citing a
so-called gmarket MAC h provision in their commitment letter and
asserting that there has been a change in the markets since
entering into the commitment.
gIt
is a well-documented fact that the ongoing conditions in the
credit markets began in the summer of 2007,h said Quinn. gWell before the banks committed to
Solutia's exit financing, they stated in public filings and
through professional advice to Solutia that the credit markets
were in disarray, and that the credit crisis would continue for
months to come. Despite their concerns and negative outlook, the
banks entered into a firm commitment to provide Solutia with this
exit financing. The willingness of these banks to offer committed
financing that was not subject to a successful syndication was a
major factor in deciding to award them this business. h
Quinn added, gSolutia is ready to emerge from
Chapter 11. We have successfully repositioned our company, we
have confirmed a plan of reorganization that brings significant
value to our constituents, and our businesses are performing
well. We now look to the banks to meet their commitment.h
---
Nov 29, 2007
Court Confirms Solutia Plan of Reorganization
Solutia Inc., a leading
manufacturer and provider of high-performance specialty materials
and chemicals, today announced that the U.S. Bankruptcy Court for
the Southern District of New York has confirmed its plan of
reorganization.
"While this has been a long process, we have used our time
in Chapter 11 to truly transform and revitalize Solutia - shaping
a strong portfolio of businesses, shedding $1.3 billion in
liabilities, and growing the company by $1 billion in sales while
more than doubling our earnings. We will emerge from Chapter 11
as a growing, vibrant company that is positioned for
success," said Jeffry N. Quinn, chairman, president and CEO,
Solutia Inc.
Quinn added, "We are pleased to have gained confirmation of
a plan of reorganization that was supported by all of the major
constituents in our case and that provides for significant
creditor recoveries."
The company anticipates that the plan of reorganization will
become effective in the late December or January timeframe.
---
Sep 26, 2007
Solutia Poised to Emerge From Bankruptcy After Reaching Settlement With All Major Constituents in Chapter 11 Case
Settlement Forms Basis
for Consensual Plan of Reorganization -- Supported by Ad Hoc
Committee of Solutia Noteholders, Official Committee of Equity
Security Holders, Official Committee of Unsecured Creditors,
Monsanto Company, Pharmacia Corporation, Official Committee of
Retirees, and Ad Hoc Committee of Trade Creditors -- Resolves
Pending Litigation and Objections -- Maintains Key Benefits of
Original Plan of Reorganization for Solutia, Including Relief
from Legacy Liabilities
Solutia Inc., a leading manufacturer and provider of
high-performance specialty materials and chemicals, today
announced it has secured the support of all of the major
constituents in its Chapter 11 cases for a consensual plan of
reorganization.
"I am extremely pleased to announce today that we have
reached a comprehensive settlement with all of the major
constituents in our bankruptcy case that will form the basis for
a revised consensual plan of reorganization that will be filed
within the next few days," said Jeffry N. Quinn, chairman,
president and chief executive officer of Solutia Inc. "The
revised plan will position Solutia to emerge from bankruptcy by
the end of this year as a financially healthy organization
well-positioned to create significant value for its
stakeholders."
"The revised plan will provide for $250 million of new
investment in reorganized Solutia through a backstopped rights
offering to certain creditors, as well as a reallocation of the
legacy liabilities that Solutia assumed when it was spun off.
Importantly, it also will provide for a resolution of all the
litigation between the settling parties including a potential
appeal by our noteholders, the adversary proceeding filed by our
current equity holders against Monsanto and Pharmacia, and
related objections to the Monsanto and Pharmacia claims."
The settlement and revised plan is supported by the Ad Hoc
Committee of Solutia Noteholders (the "noteholders"),
the Official Committee of Equity Security Holders (the
"equity security holders"), the Official Committee of
Unsecured Creditors (the "general unsecured
creditors"), Monsanto Company (NYSE:MON)
("Monsanto"), Pharmacia Corporation
("Pharmacia"), the Official Committee of Retirees (the
"retirees"), and the Ad Hoc Committee of Trade
Creditors (the "ad hoc trade creditors"). As part of
the settlement, the following parties executed agreements earlier
this month in support of the settlement and revised plan of
reorganization: Monsanto, noteholders controlling at least $300.1
million in principal amount of the 2027/2037 notes, the official
committee of general unsecured creditors, the official committee
of equity security holders, the ad hoc trade committee, and
Solutia. The support agreements became effective on September 6,
2007.
Solutia will update its disclosure statement and plan of
reorganization to reflect the terms of the settlement, and
anticipates filing these documents with the U.S. Bankruptcy Court
for the Southern District of New York promptly. An October 10,
2007 court date has been set seeking approval of the disclosure
statement. Once approved, the disclosure statement will be sent
to Solutia's creditors and equity interest holders for voting
purposes. Following the voting process, the court will hold a
hearing to approve or "confirm" the plan.
"Since beginning the chapter 11 process, we have
concentrated on the implementation of a reorganization strategy
focused on enhancing our financial and operating performance,
changing our portfolio so that it consists of high potential
businesses, and achieving a reallocation of legacy liabilities. I
am pleased to say that the men and women of Solutia have been
very successful in executing this strategy and, as a result, we
are able to provide enhanced recoveries for all creditor
constituencies, including current equity holders," added
Quinn. "The revised plan also situates us well to deliver
the fourth component of our strategy for rehabilitating our
company -- exiting bankruptcy with a competitive capital
structure."
James M. Sullivan, chief financial officer of Solutia, noted,
"Despite the recent turbulence in the debt capital markets,
I am confident that Solutia will be able to secure the necessary
exit financing package to consummate the revised plan. We have
improved our earnings, reduced our risk profile, gained the
infusion of new money investment through the rights offering, and
will propose a capital structure with moderate leverage. We are
moving forward in earnest with the exit financing process and
plan to put financing in place consistent with our emergence
timeframe."
Major Terms Underlying Settlement and Consensual Plan of
Reorganization
$250
Million of New Investment
The revised plan will provide for $250 million of new investment
in reorganized Solutia. This investment will be in the form of a
rights offering to the noteholders and general unsecured
creditors, who will be given the opportunity to purchase shares
of the new common stock on a pro rata basis at a 33.3% discount
to the implied equity value. The rights offering will be
backstopped by a group of Solutia's creditors (i.e. they will
purchase any shares not bought by other creditors). For this
commitment they will receive a fee of 2.50% and an allocation of
15% of the rights offering.
The $250 million generated as a result of the rights offering
will be used as follows: $175 million will be set aside in a
Voluntary Employees' Beneficiary Association (VEBA) Retiree Trust
to fund the retiree welfare benefits for those pre-spin retirees
whom receive these benefits from Solutia; and $75 million will be
used by Solutia to pay for other legacy liabilities being
retained by the company.
Relief
from Tort Litigation and Environmental Remediation Liabilities
Consistent with Solutia and Monsanto's prior agreement, the
settlement provides that Monsanto will take on financial
responsibilities in the areas of tort litigation and
environmental remediation.
-- Monsanto will be financially responsible for all current and
future tort litigation costs arising from Pharmacia's chemical
business prior to the Solutia spinoff. This includes litigation
arising from exposure to PCBs and other chemicals.
-- Monsanto will accept financial responsibility for
environmental remediation and clean-up obligations at all sites
for which Solutia was required to assume responsibility at the
spinoff but which were never owned or operated by Solutia.
Solutia will remain responsible for the environmental liabilities
at sites that it presently owns or operates.
-- Solutia and Monsanto will share financial responsibility with
respect to two sites. Under this cost-sharing arrangement the
first $50 million of post-emergence remediation and cleanup costs
will be funded by the proceeds of the rights offering described
above. Upon emergence, Solutia would be responsible for the
funding of these sites up to an agreed upon amount.
Thereafter, if needed, Monsanto and Solutia would share
responsibility equally.
Current
Equity Holders New Common Stock Purchase Option
Under the revised plan, in addition to the consideration
described below, current equity holders that own at least a
specified number of shares of Solutia common stock will receive
rights to purchase, at the time of the company's emergence from
bankruptcy, a pro rata share of up to 17% of the new common stock
for $175 million which is at a discount from the implied equity
value under the revised plan. The proceeds from the sale of this
equity will fund a cash payment to Monsanto of up to $175
million. Any portion of the 17% of the new common stock that is
not purchased by current equity holders will be distributed to
Monsanto under the revised plan.
Settlement
of Litigation and Claims Objection
Each of the settling parties has agreed to stay all pending
litigation relating to Solutia's chapter 11 cases until the
effective date of the plan, at which time this litigation will be
dismissed. This includes objections to the disclosure statement
and plan of reorganization filed by the noteholders and the
equity security holders, the adversary proceeding filed by the
equity security holders against Monsanto and Pharmacia,
objections to the claims filed in the case by Monsanto and
Pharmacia, and the noteholders' appeal of the decision in the
litigation related to the secured or unsecured nature of their
claims.
Composition of Board of Directors
Under the revised plan, reorganized Solutia's Board of Directors
will be comprised of nine members, including: Jeffry N. Quinn,
Solutia's chairman, president and chief executive officer; J.
Patrick Mulcahy, a current director of Solutia; one director
designated by each of Monsanto, the general unsecured creditors
and the noteholders; and four directors designated by a
five-person search committee consisting of Mr. Quinn, two
representatives from the noteholders and one representative each
from the general unsecured creditors and the ad hoc trade
creditors. Solutia has engaged the services of Spencer Stuart, a
global search firm, to begin the process of helping identify and
recommend highly qualified board candidates.
Anticipated Creditor Recoveries and Equity Ownership
Assuming full subscription to the rights offering by the
participating parties (including the backstop parties), a full
exercise of the new common stock purchase option, and an
estimated general unsecured claims pool of $342 million, the
following creditors and equity security holders will receive the
following distributions.
-- General Unsecured Creditors will receive their pro rata share
of 31.4% of the new common stock, resulting in a recovery of 80.6
cents on the dollar.
-- Noteholders will receive their pro rata share of 43.8% of the
new common stock, resulting in a recovery of 88.4 cents on the
dollar.
-- Monsanto will receive up to $175 million in cash. Any shares
of new common stock not purchased by current equity holders
pursuant to the new common stock purchase option will be
distributed to Monsanto and the cash distribution reduced
accordingly.
-- Equity Security Holders will receive their pro rate share of
1% of the new common stock and pursuant to the new common stock
purchase option described above, holders that own at least a
specified number of shares of Solutia common stock will receive
rights to purchase a pro rata share of up to 17% of the new
common stock.
Assuming the new common stock purchase option is fully exercised,
current equity security holders will own up to 18% of the new
common stock.
Additionally, current equity security holders will have the
following rights: i) holders who own at least a specified number
of shares of Solutia common stock will receive their pro rata
share of five-year warrants to purchase 7.5% of the common stock;
and ii) holders who own at least a specified number of shares of
Solutia common stock will receive the right to participate in a
buy out for cash of general unsecured claims of less than
$100,000 for an amount equal to 52.35% of the allowed amount of
such claims, subject to election of each general unsecured
creditor to sell their claim.
-- Retirees will receive the benefits provided for under the
terms of the settlement between Solutia and its retirees, which
was previously announced and is not being altered by the
settlement announced today. In accordance with that settlement,
the retirees, as a class, will receive 2% of the new common
stock.
This stock will be deposited into a VEBA trust that will be used
to pay retiree welfare benefits. This is in addition to the $175
million from the rights offering that will also be deposited into
the VEBA trust.
-- Backstop Parties (the backstoppers of the rights offering)
will own 4.7% of the new common stock.
General Plan Assumptions
Solutia will be an independent, publicly traded company listed on
a national exchange. The enterprise value of reorganized Solutia
is currently estimated to be approximately $2.85 billion, with
corresponding implied reorganization equity value of
approximately $1.2 billion. In total, 59.75 million common shares
will be issued and allocated upon emergence, exclusive of an
anticipated management incentive plan to be approved as part of
the revised plan of reorganization.
"This settlement is the result of difficult negotiations
that lead to compromise. A tremendous amount of hard work by all
of the various constituents has gone into this reorganization
process and I want to thank everyone who has been involved,"
stated Quinn.